Oculis Holding AG shares plunged >35% after both Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema failed primary ...

Australia’s access to affordable medicines could be under threat from global tensions, with one woman forced to fork out $220 ...

Key Points Interested in Oculis Holding AG? Here are five stocks we like better. Oculis' Phase 3 DIAMOND trials of OCS-01 in ...

Multiple Sclerosis can occur at any age, but most commonly affects young adults between 20 and 40 years of age ...

Selecting the right business internet type and plan is a crucial decision. You may consider various service types, including cable, DSL, and satellite, but a fiber-optic internet connection may be an ...

On World Multiple Sclerosis Day be warned hat blurred vision and eye pain may be early signs of the undiagnosed neurological ...

A VRP for home-based monitoring of visual function may be a feasible alternative to in-person exams for some neuro-ophthalmic conditions.

Vision problems are often dismissed as simple eye strain, fatigue, or the need for a new pair of glasses. But in some cases, sudden blurred vision, pain behind the eyes, or difficulty seeing colours ...

More than 51,000 people over State Pension age are receivingAttendance Allowance for visual disorders, according to the ...

The Department for Work and Pensions has confirmed a full list of eye and ear conditions that qualify state pensioners for a monthly handout. M ore than 51,000 people over State Pension age are ...

Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON) FDA Breakthrough Therapy and EMA PRIME ...